AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

4,038
Mkt Cap
$4.3B
Volume
4.46M
52W High
$15.00
52W Low
$6.69
PE Ratio
963.38
AMRX Fundamentals
Price
$13.68
Prev Close
$14.11
Open
$14.03
50D MA
$12.72
Beta
1.18
Avg. Volume
1.88M
EPS (Annual)
-$0.3783
P/B
-39.28
Rev/Employee
$336,621.33
Loading...
Loading...
News
all
press releases
AustralianSuper Pty Ltd Makes New Investment in Amneal Pharmaceuticals, Inc. $AMRX
AustralianSuper Pty Ltd acquired a new stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
If You Invested $100 In Amneal Pharmaceuticals Stock 5 Years Ago, You Would Have This Much Today
read more...
Benzinga·2d ago
News Placeholder
Amneal Pharmaceuticals (NASDAQ:AMRX) Sees Large Volume Increase - Should You Buy?
Amneal Pharmaceuticals (NASDAQ:AMRX) Sees Large Volume Increase - Should You Buy...
MarketBeat·4d ago
News Placeholder
Will Amneal (AMRX) Beat Estimates Again in Its Next Earnings Report?
Amneal (AMRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·4d ago
News Placeholder
Will Higher Dupixent Profits, Eylea HD Sales Drive REGN's Q4 Earnings?
REGN's Q4 report could hinge on Dupixent profit growth and strong Eylea HD uptake as legacy Eylea sales face competitive pressure.
Zacks·5d ago
News Placeholder
HCA Healthcare Q4 Earnings Beat Estimates on Strong Patient Volumes
HCA's Q4 EPS surge 28.8% year over year to $8.01, beating estimates on strong patient volumes and higher revenue per equivalent admission.
Zacks·5d ago
News Placeholder
Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year?
Here is how Amneal Pharmaceuticals (AMRX) and Biohaven Ltd. (BHVN) have performed compared to their sector so far this year.
Zacks·11d ago
News Placeholder
Amneal Pharmaceuticals (NASDAQ:AMRX) Reaches New 12-Month High - Here's Why
Amneal Pharmaceuticals (NASDAQ:AMRX) Hits New 12-Month High - What's Next...
MarketBeat·12d ago
News Placeholder
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Rating of "Moderate Buy" from Brokerages
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the five analysts that are covering the company, MarketBeat.com reports. One...
MarketBeat·14d ago
News Placeholder
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Sees Large Increase in Short Interest
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest...
MarketBeat·15d ago
<
1
2
...
>

Latest AMRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.